Participants 100 121 10
in healthy volunteers
Participants 447 465 5
healthy volunteers
Participants 611 676 11
Healthy male and female volunteers aged 18-75 years were included
Participants 678 904 9
All volunteers received ASA 81 mg once daily for 5 days prior to the study (pre-screen). Subjects were eligible for inclusion if they had aspirin reactivity units (ARU, as measured by the VerifyNow ASA assay) of <550 on Day 6.
Participants 1439 1559 9
A total of 29 volunteers (19 aged â‰¥50 years; 8 women; 21 men) were evaluable for pharmacodynamic analysis (per protoco
